Kojabeltan Tablet 150/12.5 mg

Adult dosage

This medication should be taken once daily, regardless of meals. 1. For adult patients whose blood pressure is not sufficiently controlled with monotherapy, administer 1 tablet of Irbesartan 150 mg/Hydrochlorothiazide 12.5 mg once daily. 2. If blood pressure is not adequately controlled, administer 1 tablet of Irbesartan 300 mg/Hydrochlorothiazide 12.5 mg or Irbesartan 300 mg/Hydrochlorothiazide 25 mg once daily.

Children's dosage

The safety and efficacy of this medication have not been established in children and adolescents under 18 years of age.

This drug can cause serious harm to the fetus and newborn during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who are pregnant or capable of becoming pregnant, as well as nursing mothers, should not take this medication. Patients with allergies to this drug or its components, certain kidney diseases, liver diseases, or anuria should not take this medication. This drug may be inappropriate for patients with severely impaired kidney function, and those with mildly impaired kidney function should use it with caution. Caution is required in patients with certain conditions such as hypotension, renal artery stenosis, liver disorders, and heart valve disease. The hydrochlorothiazide component can increase the risk of skin cancer as it reacts sensitively to sunlight, making sunblock and skin monitoring necessary during use. Side effects such as dizziness, fatigue, nausea, and vomiting may occur during the use of this drug, so if any unusual symptoms arise, consultation with a healthcare professional is necessary. Kidney function and electrolyte status should be monitored regularly through blood tests to prevent imbalances of potassium and sodium. Caution is advised when driving or operating machinery due to possible dizziness or drowsiness. There may be interactions with other medications, so it is essential to inform healthcare providers of any medications being taken. Special caution is advised when used in combination with lithium, potassium supplements, certain diuretics, antihypertensives, and non-steroidal anti-inflammatory drugs (NSAIDs). Pregnant and nursing mothers should avoid using this drug, and it is not recommended for children and adolescents due to the lack of established safety and efficacy. Elderly patients may react more sensitively to this drug and should use it with caution. Overdose may lead to hypotension, electrolyte imbalances, dehydration symptoms, which require prompt treatment and appropriate management. This drug should be stored out of reach of children and kept in its original container; altering the container is discouraged to maintain drug quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral or ocular mucosa, difficulty or shortness of breath, asthma attack, respiratory difficulty accompanied by cough + fever, jaundice (yellowing of skin or eyes), severe fatigue throughout the body, sudden and very severe headache, lightning headache, seizures, consciousness confusion, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• fatigue
• nausea/vomiting
• abnormal urination
• increased BUN
• elevated creatine kinase
• increased creatinine
• headache
• orthostatic dizziness
• syncope

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, at a temperature between 1 degree and 30 degrees Celsius at room temperature. This helps maintain the effectiveness of the drug.

Appearance

Pink, biconvex, rectangular film-coated tablet

Package unit

30 tablets/bottle